These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8585285)

  • 21. Biophysical validation of Epaxal Berna, a hepatitis A vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes (IRIV).
    Glück R; Wälti E
    Dev Biol (Basel); 2000; 103():189-97. PubMed ID: 11214236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy.
    Giammanco G; Li Volti S; Mauro L; Bilancia GG; Salemi I; Barone P; Musumeci S
    Vaccine; 1991 Oct; 9(10):747-50. PubMed ID: 1836919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of a hexavalent combination vaccine in rhesus monkeys.
    Caulfield MJ; Smith JG; Wang S; Capen RC; Blondeau C; Lentsch S; Arminjon F; Sabouraud A
    Vaccine; 2000 Nov; 19(7-8):902-7. PubMed ID: 11115714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccines.
    Bovier PA; Althaus B; Glueck R; Chippaux A; Loutan L
    J Travel Med; 1999 Dec; 6(4):228-33. PubMed ID: 10575170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.
    MMWR Recomm Rep; 1996 Nov; 45(RR-13):1-16. PubMed ID: 8965784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
    Tregnaghi M; Zambrano B; Santos-Lima E
    Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM; Friedland LR; Wu X; Howe B
    Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative evaluation of the reactogenicity and immunogenicity of inactivated influenza vaccines in the elderly].
    Burtseva EI; Slepushkin AN; Vlasova LN; Oskerko TA; Fedorova GI; Stepnova AI; Beregovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):40-5. PubMed ID: 11220963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers.
    Reutter J; Bart PA; Francioli P; Safary A; Frei PC
    J Viral Hepat; 1998 May; 5(3):205-11. PubMed ID: 9658375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.
    Squarcione S; Sgricia S; Biasio LR; Perinetti E
    Vaccine; 2003 Mar; 21(11-12):1268-74. PubMed ID: 12559808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A system for the mass combined vaccination of the adult population against influenza, viral hepatitis, typhoid, meningitis and diphtheria].
    Gapochko KG; Titova TS; Kharitonova VA; Misnikov OP; Savel'ev AP; Stepanov AV; Alliluev AP; Bichurina MA; Maksimova NM; Ozeretskovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):50-5. PubMed ID: 8067144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The reactogenic properties and antigenic activity of inactivated 3-component influenza vaccines used intranasally].
    Erofeeva MK; Maksakova VL; Mikhaĭlov AA; Kostiuchek NV; Marinich IG; Tsaritsyna IM; Shadrin AS; Subbotina TI; Sidorova LV; Voĭtsekhovskaia EM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):63-5. PubMed ID: 8079572
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
    Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
    Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routine immunization for adults.
    Med Lett Drugs Ther; 1990 Jun; 32(819):54-6. PubMed ID: 2140426
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12-18 months of age.
    Habermehl P; Leroux-Roels G; Sänger R; Mächler G; Boutriau D
    Hum Vaccin; 2010 Aug; 6(8):640-51. PubMed ID: 20697200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
    Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
    Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial.
    Holzer BR; Hatz C; Schmidt-Sissolak D; Glück R; Althaus B; Egger M
    Vaccine; 1996 Jul; 14(10):982-6. PubMed ID: 8873392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.